<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="Activity\PMC7850456\results\search\disease\results.xml">
  <result pre="Article: Research Paper Exploration of novel heterofused 1,2,4-triazine derivative in" exact="colorectal cancer" post="J. M. Hermanowicz et al. HermanowiczJustyna MagdalenaabSzymanowskaAnnacSiekluckaBeataaCzarnomysyRobertdPawlakKrystynaeBielawskaAnnacBielawskiKrzysztofdKalafutJoannafPrzybyszewskaAlicjafSurazynskiArkadiuszgRivero-MullerAdolfofMojzychMariuszhPawlakDariuszai[a], Department of"/>
  <result pre="Research Paper Exploration of novel heterofused 1,2,4-triazine derivative in colorectal" exact="cancer" post="J. M. Hermanowicz et al. HermanowiczJustyna MagdalenaabSzymanowskaAnnacSiekluckaBeataaCzarnomysyRobertdPawlakKrystynaeBielawskaAnnacBielawskiKrzysztofdKalafutJoannafPrzybyszewskaAlicjafSurazynskiArkadiuszgRivero-MullerAdolfofMojzychMariuszhPawlakDariuszai[a], Department of"/>
  <result pre="provided the original work is properly cited.IENZ_36_1879803.pdf Abstract Abstract Colorectal" exact="cancer" post="(CRC) is the third leading cause of cancer-related deaths"/>
  <result pre="of the new pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulphonamide (MM-129) was evaluated against human" exact="colon cancer" post="inÂ vitro and in zebrafish xenografts. Our results show"/>
  <result pre="the new pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulphonamide (MM-129) was evaluated against human colon" exact="cancer" post="inÂ vitro and in zebrafish xenografts. Our results show"/>
  <result pre="evaluation as chemotherapeutic agent against CRC. Keywords 1,2,4-Triazine derivative apoptosis" exact="colon cancer" post="zebrafish fig-count: table-count: page-count: word-count: 1. Introduction Colorectal cancer"/>
  <result pre="as chemotherapeutic agent against CRC. Keywords 1,2,4-Triazine derivative apoptosis colon" exact="cancer" post="zebrafish fig-count: table-count: page-count: word-count: 1. Introduction Colorectal cancer"/>
  <result pre="colon cancer zebrafish fig-count: table-count: page-count: word-count: 1. Introduction Colorectal" exact="cancer" post="(CRC) is the third leading cause of cancer-related deaths"/>
  <result pre="found to have dose-dependent antiproliferative effects against two Bcr-Abl positive" exact="cancer" post="cell lines, K562 and BV173. Therefore, they were tested"/>
  <result pre="condensed with triazole or tetrazole were the most active against" exact="cancer" post="cell lines17,18. Replacement of triazole with a tetrazole ring"/>
  <result pre="cell lines of CRC). It showed potent antiproliferative effects against" exact="colon cancer" post="cell lines with IC50 values 3.1Â ÂµM compared to"/>
  <result pre="lines of CRC). It showed potent antiproliferative effects against colon" exact="cancer" post="cell lines with IC50 values 3.1Â ÂµM compared to"/>
  <result pre="these models with anticancer drug 5-FU, used clinically to treat" exact="cancer" post="patients. We found that MM-129 effectively inhibits tumour development"/>
  <result pre="were carried out. 2.3. Zebrafish handling, establishment of xenograft Colon" exact="cancer" post="DLD-1 and HT-29 cells were transfected before transplantation. The"/>
  <result pre="agarose to stabilise the fish in a lateral position. Colon" exact="cancer" post="cells were loaded into a borosilicate glass needle pulled"/>
  <result pre="and stains cells with a green fluorescent. DLD-1 and HT-29" exact="colon cancer" post="cell lines covering about 80% of the plate were"/>
  <result pre="stains cells with a green fluorescent. DLD-1 and HT-29 colon" exact="cancer" post="cell lines covering about 80% of the plate were"/>
  <result pre="with MM-129+5-FU significantly intensified the reduction in the number of" exact="cancer" post="cells in both DLD-1 (30.12â€‰Â±â€‰15.83) and HT-29 (40.0â€‰Â±â€‰13.42) xenografts"/>
  <result pre="tumour development (a). Site-specific injection (yolk sac) of transfected (red)" exact="colon cancer" post="cells (DLD-1 and HT-29) into 48Â hpf zebrafish embryos"/>
  <result pre="development (a). Site-specific injection (yolk sac) of transfected (red) colon" exact="cancer" post="cells (DLD-1 and HT-29) into 48Â hpf zebrafish embryos"/>
  <result pre="combination of these agents (b). Quantification of total fluorescence by" exact="colon cancer" post="cells threeÂ days after injection (c) nâ€‰=â€‰8, *pâ€‰ pâ€‰"/>
  <result pre="of these agents (b). Quantification of total fluorescence by colon" exact="cancer" post="cells threeÂ days after injection (c) nâ€‰=â€‰8, *pâ€‰ pâ€‰"/>
  <result pre="incorporation of radioactive labelled thymidine into the DNA of the" exact="cancer" post="cells after 24-h incubation with various concentrations of the"/>
  <result pre="lines. Figure 4. Viability of DLD-1 (a) and HT-29 (b)" exact="colon cancer" post="cells treated for 24â€‰h with different concentrations of MM-129,"/>
  <result pre="Figure 4. Viability of DLD-1 (a) and HT-29 (b) colon" exact="cancer" post="cells treated for 24â€‰h with different concentrations of MM-129,"/>
  <result pre="of the studied compounds in DLD-1 (c) and HT-29 (d)" exact="colon cancer" post="cells measured by the inhibition of [3H]thymidine incorporation into"/>
  <result pre="the studied compounds in DLD-1 (c) and HT-29 (d) colon" exact="cancer" post="cells measured by the inhibition of [3H]thymidine incorporation into"/>
  <result pre="the cytotoxic activity of pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine derivatives against DLD-1 and HT-29" exact="cancer" post="cells is due to the induction of PCD. Figure"/>
  <result pre="annexin Vâ€�FITC-propidium iodide assay of DLD-1 (a) and HT-29 (b)" exact="colon cancer" post="cells after 24â€‰h of incubation with roscovitine (RSC), 5-fluorouracil"/>
  <result pre="Vâ€�FITC-propidium iodide assay of DLD-1 (a) and HT-29 (b) colon" exact="cancer" post="cells after 24â€‰h of incubation with roscovitine (RSC), 5-fluorouracil"/>
  <result pre="mitochondrial membrane potential (Î&quot;Î¨m) of DLD-1 (a) and HT-29 (b)" exact="colon cancer" post="cells treated for 24â€‰h with roscovitine (RSC), 5-fluorouracil (5-FU),"/>
  <result pre="membrane potential (Î&quot;Î¨m) of DLD-1 (a) and HT-29 (b) colon" exact="cancer" post="cells treated for 24â€‰h with roscovitine (RSC), 5-fluorouracil (5-FU),"/>
  <result pre="(a, c, e, g) and HT-29 (b, d, f, h)" exact="colon cancer" post="cells treated for 24â€‰h with roscovitine (RSC), 5-fluorouracil (5-FU),"/>
  <result pre="c, e, g) and HT-29 (b, d, f, h) colon" exact="cancer" post="cells treated for 24â€‰h with roscovitine (RSC), 5-fluorouracil (5-FU),"/>
  <result pre="The antitumor action of this chemotherapeutic has been tested using" exact="cancer" post="xenografts of LoVo human CRC cells, MESSA-DX5 human uterine"/>
  <result pre="cells, MESSA-DX5 human uterine carcinoma cells, or MDA-MB 231 human" exact="breast cancer" post="cells grafted into CD1 nude mice36,37. The aim of"/>
  <result pre="MESSA-DX5 human uterine carcinoma cells, or MDA-MB 231 human breast" exact="cancer" post="cells grafted into CD1 nude mice36,37. The aim of"/>
  <result pre="treatment of patients with colorectal carcinoma. Undoubtedly, this kind of" exact="cancer" post="is a significant problem, both from the medical and"/>
  <result pre="on new 1,2,4-triazine derivative using cell lines and a zebrafish" exact="cancer" post="model. The anticancer action of MM-129 was investigated in"/>
  <result pre="xenografts) and 64% (HT-29 xenografts) reduction in the number of" exact="cancer" post="cells compared with the control group. A basic element"/>
  <result pre="cells compared with the control group. A basic element of" exact="colon cancer" post="treatment is surgery, which is aimed at obtaining intestinal"/>
  <result pre="compared with the control group. A basic element of colon" exact="cancer" post="treatment is surgery, which is aimed at obtaining intestinal"/>
  <result pre="often used as a strong and cost-effective animal model for" exact="cancer" post="research and the discovery of cancer drugs. The small"/>
  <result pre="cost-effective animal model for cancer research and the discovery of" exact="cancer" post="drugs. The small size, transparency of zebrafish embryos, easy"/>
  <result pre="of RSC with IC50 ranging from 15 to 25â€‰Î¼M in" exact="multiple myeloma" post="cells, from 18 to 22Â ÂµM in cervical carcinoma"/>
  <result pre="also in other solid tumours, including breast, ovarian, prostate, and" exact="colon cancer" post="(BJP)43â€&quot;47. Furthermore overexpression of this kinase in colon cancer"/>
  <result pre="in other solid tumours, including breast, ovarian, prostate, and colon" exact="cancer" post="(BJP)43â€&quot;47. Furthermore overexpression of this kinase in colon cancer"/>
  <result pre="and colon cancer (BJP)43â€&quot;47. Furthermore overexpression of this kinase in" exact="colon cancer" post="has previously been observed47. To investigate the mechanism involved"/>
  <result pre="colon cancer (BJP)43â€&quot;47. Furthermore overexpression of this kinase in colon" exact="cancer" post="has previously been observed47. To investigate the mechanism involved"/>
  <result pre="apoptosis-dependent cell death. First, we noticed significant accumulation of apoptotic" exact="colon cancer" post="cells with externalised PS after incubation with MM-129. To"/>
  <result pre="cell death. First, we noticed significant accumulation of apoptotic colon" exact="cancer" post="cells with externalised PS after incubation with MM-129. To"/>
  <result pre="synthesised 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives and demonstrated that they determined apoptosis in" exact="cancer" post="cells by inducing a loss of MMP52. Mechanism studies"/>
  <result pre="be an attractive alternative to the already existing methods of" exact="colon cancer" post="treatment. Supplementary Material Supplemental Material LINK Click here for"/>
  <result pre="an attractive alternative to the already existing methods of colon" exact="cancer" post="treatment. Supplementary Material Supplemental Material LINK Click here for"/>
  <result pre="JAMA Surg2015;150:245â€&quot;51.25588105 3ForsterS, RadpourR.Molecular immunotherapy: promising approach to treat metastatic" exact="colorectal cancer" post="by targeting resistant cancer cells or cancer stem cells."/>
  <result pre="Surg2015;150:245â€&quot;51.25588105 3ForsterS, RadpourR.Molecular immunotherapy: promising approach to treat metastatic colorectal" exact="cancer" post="by targeting resistant cancer cells or cancer stem cells."/>
  <result pre="promising approach to treat metastatic colorectal cancer by targeting resistant" exact="cancer" post="cells or cancer stem cells. Front Oncol2020;10:569017.33240813 4LizardoDY, KuangC,"/>
  <result pre="treat metastatic colorectal cancer by targeting resistant cancer cells or" exact="cancer" post="stem cells. Front Oncol2020;10:569017.33240813 4LizardoDY, KuangC, HaoS, et al.Immunotherapy"/>
  <result pre="J Med Chem2014;78:217â€&quot;24.24681986 17MojzychM.Cytotoxic activity of some pyrazolo[4,3-e][1,2,4]triazine against human" exact="cancer" post="cell lines. J Chem Soc Pak2011;33:123â€&quot;8. 18MojzychM, TarasiukP, KarczmarzykZ,"/>
  <result pre="sulfonamide derivatives on apoptosis and autophagy in DLD-1 and HT-29" exact="colon cancer" post="cells. Int J Mol Sci2020;21:5221. 20ScottGR, JohnstonIA.Temperature during embryonic"/>
  <result pre="derivatives on apoptosis and autophagy in DLD-1 and HT-29 colon" exact="cancer" post="cells. Int J Mol Sci2020;21:5221. 20ScottGR, JohnstonIA.Temperature during embryonic"/>
  <result pre="USA2011;108:8414â€&quot;9.21536883 25XuZ, HuC, ChenS, et al.Apatinib enhances chemosensitivity of gastric" exact="cancer" post="to paclitaxel and 5-fluorouracil. Cancer Manag Res2019;11:4905â€&quot;15.31213909 26Tankiewicz-KwedloA, HermanowiczJM,"/>
  <result pre="et al.Erythropoietin enhances the cytotoxic effect of hydrogen peroxide on" exact="colon cancer" post="cells. Curr Pharm Biotechnol2017;18:127â€&quot;37.27903235 27Tankiewicz-KwedloA, HermanowiczJM, DomaniewskiT, et al.Simultaneous"/>
  <result pre="al.Erythropoietin enhances the cytotoxic effect of hydrogen peroxide on colon" exact="cancer" post="cells. Curr Pharm Biotechnol2017;18:127â€&quot;37.27903235 27Tankiewicz-KwedloA, HermanowiczJM, DomaniewskiT, et al.Simultaneous"/>
  <result pre="of erythropoietin and LFM-A13 as a new therapeutic approach for" exact="colorectal cancer." post="Br J Pharmacol2018;175:743â€&quot;62.29160911 28Tankiewicz-KwedloA, HermanowiczJM, PawlakK, et al.Erythropoietin intensifies"/>
  <result pre="of LFM-A13 in cells and in a mouse model of" exact="colorectal cancer." post="Int J Mol Sci2018;19:1262. 29MojzychM, RykowskiA.Synthesis of functionalized 1H-pyrazolo[4,3-e][1,2,4]triazines"/>
  <result pre="N-, S- and C-nucleophiles. Heterocycles2004;63:1829â€&quot;38. 30UckunFM, DibirdikI, QaziS, et al.Anti-breast" exact="cancer" post="activity of LFM-A13, a potent inhibitor of Polo-like kinase"/>
  <result pre="cyclin-dependent kinases in cell-cycle progression and therapeutic strategies in human" exact="breast cancer." post="Int J Mol Sci2020;21:1960. 34AldossIT, TashiT, GantiAK.Seliciclib in malignancies."/>
  <result pre="cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in" exact="multiple myeloma." post="Blood2005;106:1042â€&quot;7.15827128 39CuiC, WangY, WangY, et al.Exploring the relationship between"/>
  <result pre="relationship between the inhibition selectivity and the apoptosis of roscovitine-treated" exact="cancer" post="cells. J Anal Methods Chem2013;2013:389390.23691435 40KolodziejM, GoetzC, Di FazioP,"/>
  <result pre="a pilot study. Oncol Rep2015;34:1549â€&quot;56.26151768 41MhaidatNM, BouklihaceneM, ThorneRF.5-Fluorouracil-induced apoptosis in" exact="colorectal cancer" post="cells is caspase-9-dependent and mediated by activation of protein"/>
  <result pre="pilot study. Oncol Rep2015;34:1549â€&quot;56.26151768 41MhaidatNM, BouklihaceneM, ThorneRF.5-Fluorouracil-induced apoptosis in colorectal" exact="cancer" post="cells is caspase-9-dependent and mediated by activation of protein"/>
  <result pre="novel isoform of the B cell tyrosine kinase BTK protects" exact="breast cancer" post="cells from apoptosis. Genes Chromosomes Cancer2013;52:961â€&quot;75.23913792 45ZuchaMA, WuAT, LeeWH,"/>
  <result pre="isoform of the B cell tyrosine kinase BTK protects breast" exact="cancer" post="cells from apoptosis. Genes Chromosomes Cancer2013;52:961â€&quot;75.23913792 45ZuchaMA, WuAT, LeeWH,"/>
  <result pre="al.Brutonâ€™s tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in" exact="ovarian cancer." post="Oncotarget2015;6:13255â€&quot;68.26036311 46GuoW, LiuR, BhardwajG, et al.Targeting Btk/Etk of prostate"/>
  <result pre="ovarian cancer. Oncotarget2015;6:13255â€&quot;68.26036311 46GuoW, LiuR, BhardwajG, et al.Targeting Btk/Etk of" exact="prostate cancer" post="cells by a novel dual inhibitor. Cell Death Dis2014;5:e1409.25188519"/>
  <result pre="cancer. Oncotarget2015;6:13255â€&quot;68.26036311 46GuoW, LiuR, BhardwajG, et al.Targeting Btk/Etk of prostate" exact="cancer" post="cells by a novel dual inhibitor. Cell Death Dis2014;5:e1409.25188519"/>
  <result pre="Mateo-LozanoS, NotarioV.Roscovitine is an effective inducer of apoptosis of Ewingâ€™s" exact="sarcoma" post="family tumor cells inÂ vitro and inÂ vivo. Cancer"/>
 </snippets>
</snippetsTree>
